Chantibody Platforms

VHHMAb®

MultiVHH™

MultiVHH™

1. HT antigen-specific B-cells isolation & amplification with multiple binding formats plus conventional phage display technology
2. Repertoire NGS analysis with Ab intelligences to target drug-able and other applicable sequences
3. Fully utilize camelids VHH and VH/NL repertoires to develop the best-in-class/ first-in-class drug leads

MultiVHH™

MultiVHH™

MultiVHH™

1. Take advantage of VHHMAb® to select lineage-based sequences for multi-specific library construction
2. Based on epitope geometry and Ab intelligences to design optimal linker(s), guided by thermodynamic formula
3. Biology-based HT functional screening capability for drug leads

PathoVHH™

MultiVHH™

PathoVHH™

1. Utilize native immunogen source (cells/tissues) to generate VHH "bank" to protein, non-protein (glycol, lipid) and their complex with VHHMAb®
2. HT differentiated screening strategy to discover disease-specific antibodies
3. HT methodologies for targets identification with Ab intelligences